Genome editing to model and reverse a prevalent mutation associated with myeloproliferative neoplasms

Ron Baik; Stacia K. Wyman; Shaheen Kabir; Jacob E. Corn

doi:10.1101/855452

Article Information

doi

https://doi.org/10.1101/855452

History

November 26, 2019.

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

Ron Baik1,2,3,
Stacia K. Wyman1,2,
Shaheen Kabir1,2,4,* and
Jacob E. Corn1,2,5,*

¹Innovative Genomics Institute, University of California, Berkeley, CA 94720
²Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720
³Department of Pediatrics, Stanford University, Stanford, CA 94305
⁴Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94158
⁵Department of Biology, ETH Zurich, Switzerland